J&J Building Competitive Advantages In CMS Skills And Drug-Device Combos
This article was originally published in The Gray Sheet
Executive Summary
Cordis began working with the Centers for Medicare & Medicaid Services on reimbursement for Cypher as soon as the sirolimus stent entered clinical trials, Cordis World Wide Group Chairman Bob Croce told the Wharton Health Care Business Conference Feb. 20 in Philadelphia
You may also be interested in...
FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews
Routine sharing of data between FDA and CMS will be possible for the first time under a June 23 memorandum of understanding that could serve as a first step toward parallel reviews for marketing approval and Medicare coverage
FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews
Routine sharing of data between FDA and CMS will be possible for the first time under a June 23 memorandum of understanding that could serve as a first step toward parallel reviews for marketing approval and Medicare coverage
Critical Path To Payment? Venture Capitalists Seek Medicare Refocus
The National Venture Capital Association is lobbying CMS to make better use of its Council on Technology & Innovations to streamline and standardize the reimbursement process for novel technologies